Dimensional Fund Advisors LP 13D and 13G filings for Supernus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-21 1:21 pm Sale | 2025-12-31 | 13G | SUPERNUS PHARMACEUTICALS INC C SUPN | Dimensional Fund Advisors LP | 2,712,341 4.700% | -170,164 (-5.90%) | Filing |
| 2024-10-31 11:55 am Purchase | 2024-10-31 | 13G | SUPERNUS PHARMACEUTICALS INC C SUPN | Dimensional Fund Advisors LP | 2,882,505 5.200% | 2,882,505 (New Position) | Filing |